Filter
417
Text search:
booster
Featured
Recommendations
35
New Publications
90
Language
Document type
No document type
197
Guidelines
94
Studies & Reports
48
Fact sheets
25
Manuals
17
Strategic & Response Plan
13
Situation Updates
7
Training Material
6
Brochures
4
Resource Platforms
2
Infographics
2
Videos
2
Countries / Regions
India
27
Global
19
South Africa
11
Western and Central Europe
9
Brazil
8
Africa
8
Congo, Democratic Republic of
7
Philippines
7
Mozambique
7
Ukraine
7
Senegal
6
Germany
6
Tanzania
6
Argentina
6
Namibia
6
Latin America and the Carribbean
6
Zambia
5
Nigeria
4
Colombia
4
Lesotho
4
East and Southern Africa
4
Ghana
3
Uganda
3
Kenya
3
Rwanda
3
Myanmar / Burma
3
Liberia
2
Zimbabwe
2
Nepal
2
Indonesia
2
Benin
2
West and Central Africa
2
South–East Asia Region
2
Western Pacific Region
2
Venezuela
2
Eastern Europe
2
Burkina Faso
1
Sierra Leone
1
Niger
1
Haiti
1
Bangladesh
1
Switzerland
1
Ecuador
1
Botswana
1
Madagascar
1
Chile
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Russia
1
Moldova
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
150
Clinical Guidelines
71
Women & Child Health
23
Public Health
19
Key Resources
6
Capacity Building
3
Pharmacy & Technologies
2
Toolboxes
COVID-19
88
TB
24
HIV
21
Mental Health
18
Polio
13
Refugee
13
Rapid Response
12
NTDs
12
Pharmacy
10
Conflict
9
Caregiver
8
Ebola
5
Natural Hazards
5
Planetary Health
5
AMR
4
NCDs
4
Disability
2
Cholera
2
Global Health Education
2
Health Financing Toolbox
2
Specific Hazards
1
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat
...
This document offers public health guidance for the prevention and control of COVID-19 in reception centres, and other temporary accommodation facilities, in the context of the mass influx of Ukrainian people into the European Union (EU), the European Economic Area (EEA) and the Republic of Moldova.
...
www.i-Base.info
Accessed: 28.11.2019
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing
...
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
31 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
Vaccines are a critical tool in the battl
...
Accessed 7 July 2015
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
Q13: What is the effectiveness of behaviour change techniques including life skills education in promoting mental health for children and adolescents?
Disease outbreak news, 21 November 2019
The objectives of pertussis surveillance are to:hmonitor disease burden and the impact of the pertussis vaccination programme, with a special focus on understanding the morbidity and mortality in children < 5 years of agehgenerate data to inform vaccine schedule and delivery strategy decisions to optimize the impact of
...
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
